Member Log-in

I forgot my password

Not a Member? Register

New Guide Helps Countries Assess Immunization Financing Options

Helen Saxenian, Cheryl Cashin, and Paul Wilson, Results for Development

Maintaining high rates of immunization coverage, which is essential for a persistent reduction in the incidence of vaccine-preventable infectious diseases, requires a sufficient and sustained investment. In order to ensure that governments are making adequate investments in immunization financing and are doing so through sustainable policies, advocates and policymakers must be equipped with up-to-date information regarding the full array of policy options, strategies, and challenges of innovative immunization financing.

A new resource guide—funded by the Bill & Melinda Gates Foundation and developed by Results for Development—seeks to provide this information in a single source.

Immunization Financing: A Resource Guide for Advocates, Policymakers, and Program Managers was formally released on February 21, 2017. The guide is an update to the Immunization Financing Toolkit: A Resource for Policy-Makers and Program Managers, published by the World Bank and the Gavi Alliance in December 2010. Since the publication of the toolkit in 2010, several important trends have emerged, including new vaccines added to national schedules, increased country transitions from Gavi support, and growing commitments to immunization financing and universal health coverage.

The new guide is comprised of 26 briefs, with eight country case studies, and is intended for both Gavi and non-Gavi eligible countries. Copies are available for download at www.immunizationfinancing.org. French, Spanish, and Russian translations of the guide are available on the website as well.

You May Also Like

TVEE Publishes Open Source Health Economics Courses on OpenCourseWare

The Teaching Vaccine Economics Everywhere (TVEE) project is pleased to announce that three modules from its vaccine economics curriculum are now available to the public for free on the JHSPH OpenCourseWare (OCW). The modules published are Health Economics for Vaccines, Costing in Vaccine Planning and Programming, and Economic Evaluation and are available here. Anybody can … Continued

The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries

A team of researchers modeled the equity impact of lives saved and medical impoverishment averted from immunization over the period 2016-30 in 41 low and middle income countries (DHS survey availability determined which countries were selected for inclusion). Of our 15 LNCT member countries, data from Armenia, Ghana, Indonesia, Nigeria, and Timor-Leste were included in … Continued

New Rotavirus Vaccine Prequalified by WHO

Bharat Biotech announced that ROTAVAC® has achieved pre-qualification by the World Health Organization (WHO), making it available for procurement by United Nations agencies and GAVI, the Vaccine Alliance, for use in low-resource countries. ROTAVAC is substantially cheaper than current rotavirus vaccines on the global market and will be available at $1/dose. Read more about ROTAVAC’s … Continued

Choose a Language